Predicting lupus membranous nephritis using reduced picolinic acid to tryptophan ratio as a urinary biomarker

The current gold standard for classifying lupus nephritis (LN) progression is a renal biopsy, which is an invasive procedure. Undergoing a series of biopsies for monitoring disease progression and treatments is unlikely suitable for patients with LN. Thus, there is an urgent need for non-invasive al...

Descripción completa

Detalles Bibliográficos
Autores principales: Anekthanakul, Krittima, Manocheewa, Siriphan, Chienwichai, Kittiphan, Poungsombat, Patcha, Limjiasahapong, Suphitcha, Wanichthanarak, Kwanjeera, Jariyasopit, Narumol, Mathema, Vivek Bhakta, Kuhakarn, Chutima, Reutrakul, Vichai, Phetcharaburanin, Jutarop, Panya, Atikorn, Phonsatta, Natthaporn, Visessanguan, Wonnop, Pomyen, Yotsawat, Sirivatanauksorn, Yongyut, Worawichawong, Suchin, Sathirapongsasuti, Nuankanya, Kitiyakara, Chagriya, Khoomrung, Sakda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590081/
https://www.ncbi.nlm.nih.gov/pubmed/34805802
http://dx.doi.org/10.1016/j.isci.2021.103355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590081/
https://www.ncbi.nlm.nih.gov/pubmed/34805802
http://dx.doi.org/10.1016/j.isci.2021.103355

Ejemplares similares